Clinical trials sponsored by Almirall, S.A.
4
Recruiting trials
6
Conditions studied
Phase breakdown
Phase 3 1Not applicable 3
Conditions studied
| Condition | Trials |
|---|---|
| Eczema | 2 |
| Psoriasis | 2 |
| Atopic Dermatitis | 1 |
| Genital Psoriasis | 1 |
| Nummular Eczema | 1 |
| Plaque Psoriasis | 1 |
Recruiting trials led by Almirall, S.A.
- A Study of Lebrikizumab in Adults With Nummular Eczema
- A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
- A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
- A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
Common questions
How many trials is Almirall, S.A. recruiting for?
Almirall, S.A. is the lead sponsor of 4 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.